Clorox Company (The) (CLX) Stake Held by Cypress Capital Group

Cypress Capital Group held its stake in shares of Clorox Company (The) (NYSE:CLX) during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 5,736 shares of the company’s stock at the close of the second quarter. Cypress Capital Group’s holdings in Clorox Company (The) were worth $764,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also made changes to their positions in the stock. Jacobi Capital Management LLC lifted its position in Clorox Company (The) by 0.3% in the 1st quarter. Jacobi Capital Management LLC now owns 1,282 shares of the company’s stock valued at $172,000 after acquiring an additional 4 shares in the last quarter. Bridgeworth LLC lifted its position in Clorox Company (The) by 0.3% in the 1st quarter. Bridgeworth LLC now owns 1,869 shares of the company’s stock valued at $252,000 after acquiring an additional 5 shares in the last quarter. Valley National Advisers Inc. lifted its position in Clorox Company (The) by 0.6% in the 1st quarter. Valley National Advisers Inc. now owns 860 shares of the company’s stock valued at $116,000 after acquiring an additional 5 shares in the last quarter. Bernzott Capital Advisors lifted its position in Clorox Company (The) by 0.4% in the 2nd quarter. Bernzott Capital Advisors now owns 1,607 shares of the company’s stock valued at $214,000 after acquiring an additional 7 shares in the last quarter. Finally, Janney Capital Management LLC lifted its position in Clorox Company (The) by 0.5% in the 2nd quarter. Janney Capital Management LLC now owns 1,611 shares of the company’s stock valued at $214,000 after acquiring an additional 8 shares in the last quarter. 71.33% of the stock is currently owned by institutional investors and hedge funds.

Shares of Clorox Company (CLX) traded up 1.01% during midday trading on Wednesday, hitting $130.53. 206,977 shares of the stock traded hands. Clorox Company has a 52 week low of $111.24 and a 52 week high of $141.76. The company’s 50-day moving average is $134.03 and its 200 day moving average is $134.44. The firm has a market capitalization of $16.83 billion, a PE ratio of 24.40 and a beta of 0.39.

Clorox Company (The) (NYSE:CLX) last announced its earnings results on Thursday, August 3rd. The company reported $1.53 EPS for the quarter, beating the Zacks’ consensus estimate of $1.49 by $0.04. Clorox Company (The) had a net margin of 11.74% and a return on equity of 190.67%. The business had revenue of $1.65 billion during the quarter, compared to analysts’ expectations of $1.65 billion. During the same period in the prior year, the company earned $1.30 earnings per share. The firm’s revenue was up 2.9% on a year-over-year basis. Analysts anticipate that Clorox Company will post $5.64 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Monday, November 13th. Shareholders of record on Wednesday, October 25th will be issued a dividend of $0.84 per share. The ex-dividend date is Tuesday, October 24th. This represents a $3.36 dividend on an annualized basis and a yield of 2.60%. Clorox Company (The)’s dividend payout ratio is currently 63.04%.

In other Clorox Company (The) news, SVP Jon M. Balousek sold 9,223 shares of the company’s stock in a transaction that occurred on Wednesday, August 23rd. The shares were sold at an average price of $138.87, for a total transaction of $1,280,798.01. Following the completion of the sale, the senior vice president now directly owns 20,614 shares of the company’s stock, valued at $2,862,666.18. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP James E. Foster sold 9,861 shares of the company’s stock in a transaction that occurred on Wednesday, August 23rd. The shares were sold at an average price of $138.51, for a total transaction of $1,365,847.11. Following the sale, the executive vice president now directly owns 22,069 shares of the company’s stock, valued at $3,056,777.19. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 21,242 shares of company stock valued at $2,944,449. 1.00% of the stock is owned by corporate insiders.

COPYRIGHT VIOLATION NOTICE: This piece was originally posted by Sports Perspectives and is the property of of Sports Perspectives. If you are viewing this piece on another publication, it was illegally stolen and republished in violation of US and international copyright & trademark legislation. The correct version of this piece can be read at https://sportsperspectives.com/2017/10/11/clorox-company-the-clx-stake-held-by-cypress-capital-group.html.

Several equities analysts have commented on CLX shares. Zacks Investment Research raised shares of Clorox Company (The) from a “hold” rating to a “buy” rating and set a $149.00 target price on the stock in a research report on Tuesday, July 4th. BMO Capital Markets set a $150.00 target price on shares of Clorox Company (The) and gave the stock a “buy” rating in a research report on Thursday, August 3rd. Barclays PLC reissued an “equal weight” rating and set a $136.00 target price (down previously from $140.00) on shares of Clorox Company (The) in a research report on Friday, August 4th. Royal Bank Of Canada reissued a “hold” rating and set a $115.00 target price on shares of Clorox Company (The) in a research report on Wednesday, August 2nd. Finally, Deutsche Bank AG reissued a “hold” rating and set a $137.00 target price (up previously from $126.00) on shares of Clorox Company (The) in a research report on Saturday, July 22nd. Three investment analysts have rated the stock with a sell rating, nine have given a hold rating and two have issued a buy rating to the company’s stock. Clorox Company (The) currently has a consensus rating of “Hold” and a consensus price target of $127.39.

Clorox Company (The) Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Institutional Ownership by Quarter for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply